Beyond the Off-Label: A Systematic Review of What We Know About Clozapine Use for Children

被引:2
|
作者
Pimenta de Figueiredo, Thales [1 ]
de Almeida, Igor Ribeiro [1 ]
de Freitas, Filipe Augusto Cursino [2 ]
Kubrusly, Caio Hage Chahine [1 ]
Alvim-Soares Jr, Antonio Marcos [1 ]
de Miranda, Debora Marques [1 ]
机构
[1] Univ Fed Minas Gerais, 190 Ave Prof Alfredo Balena, BR-30130100 Belo Horizonte, MG, Brazil
[2] Fundacao Hosp Estado Minas Gerais, Belo Horizonte, Brazil
关键词
clozapine; children; psychopharmacology; aggressive behavior; DOUBLE-BLIND; ADOLESCENTS; ANTIPSYCHOTICS; AGGRESSION; DISORDER; YOUTHS;
D O I
10.1089/cap.2024.0070
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Introduction: It is essential not to delay behavior management and control for aggression, violence, and impulsive behavior in young people. Clozapine has been widely used in adolescents and adults to manage violence and aggression in Schizophrenia. However, there are limited data on the use of clozapine in children, and no systematic review has addressed its use in this population.Objective and Methods: To better understand the conditions under which clozapine is used as a therapeutic alternative for nonschizophrenic diagnoses and to assess the current evidence supporting its prescription to children, a systematic review was conducted. The review followed PRISMA guidelines and was registered in PROSPERO under the ID CRD42024537707.Results: The review identified that all the studies used clozapine to address externalizing behavior, particularly aggressive behavior, and found positive outcomes supporting its use for treating children with treatment-resistant aggression. The studies also found that clozapine was well-tolerated in all cases. However, the studies were limited and mainly consisted of open trials without a control group.Conclusion: Further high-quality research is needed to establish precise guidelines for using clozapine in children.
引用
收藏
页码:e419 / e426
页数:8
相关论文
共 50 条
  • [21] A systematic review on the off-label use of montelukast in atopic dermatitis treatment
    Chin, Weng Khong
    Lee, Shaun Wen Huey
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2018, 40 (05) : 963 - 976
  • [22] Off-label use of rituximab in systemic lupus erythematosus: a systematic review
    Eleanor Murray
    Martin Perry
    Clinical Rheumatology, 2010, 29 : 707 - 716
  • [23] What we know and what we don't know about the perioperative use of methadone in children and adolescents
    Boisvert-Plante, Virginie
    Poulin-Harnois, Christelle
    Ingelmo, Pablo
    Einhorn, Lisa M.
    PEDIATRIC ANESTHESIA, 2023, 33 (03) : 185 - 192
  • [24] Off-Label Use - Pain Therapy in Children
    Biermann, E.
    Pfundstein, A.
    ANASTHESIOLOGIE & INTENSIVMEDIZIN, 2019, 60 : V34 - V36
  • [25] Off-label prescription drug use in children
    McPhillips, HA
    Davis, RL
    Hecht, JA
    Stille, CJ
    PEDIATRIC RESEARCH, 2003, 53 (04) : 205A - 205A
  • [26] Off-label drug use in hospitalized children
    Shah, Samir S.
    Hall, Matthew
    Goodman, Denise M.
    Feuer, Pamela
    Sharma, Vidya
    Fargason, Crayton, Jr.
    Hyman, Daniel
    Jenkins, Kathy
    White, Marjorie L.
    Levy, Fiona H.
    Levin, James E.
    Bertoch, David
    Slonim, Anthony D.
    ARCHIVES OF PEDIATRICS & ADOLESCENT MEDICINE, 2007, 161 (03): : 282 - 290
  • [28] Evaluating the off-label use of medications in children
    Eiland, Lea S.
    Knight, Patrice
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2006, 63 (11) : 1062 - 1065
  • [29] Off-Label Use of Medical Devices in Children
    Jenkins, Kathy J.
    Beekman, Robert H.
    Vitale, Michael G.
    Hennrikus, William L.
    PEDIATRICS, 2017, 139 (01)
  • [30] What do we know about femvertising? A systematic literature review
    Vandellos, Emma
    Villarroya, Anna
    Bote-Vericad, Juan-Jose
    CUADERNOS INFO, 2023, (56) : 185 - 204